41 related articles for article (PubMed ID: 11896827)
1. Does Loss of Immunohistochemical Expression of Glypican 3 in Oral Squamous Cell Carcinoma Play a Role in the Wnt/β-catenin Signaling Pathway?
Jot K; Urs AB; Kumar P
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):693-699. PubMed ID: 34091531
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Expression of Aquaporin 3 Antigen-Recognition Sites in Oral Squamous Cell Carcinoma.
Udompatanakorn C; Yada N; Matsuo K
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):611-620. PubMed ID: 31373900
[TBL] [Abstract][Full Text] [Related]
3. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy upregulated immune checkpoints contribute to the development of second primary OSCC.
Wang L; Wang S; Zhang J; Peng J; Cheng B; Li H; Hu Q
Oral Dis; 2024 May; 30(4):2188-2201. PubMed ID: 37213085
[TBL] [Abstract][Full Text] [Related]
5. c-FOS drives reversible basal to squamous cell carcinoma transition.
Kuonen F; Li NY; Haensel D; Patel T; Gaddam S; Yerly L; Rieger K; Aasi S; Oro AE
Cell Rep; 2021 Oct; 37(1):109774. PubMed ID: 34610301
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Study on the Expression of CLLD7 and CHC1L Proteins in Oral Squamous Cell Carcinoma.
Klongnoi B; Bhattarai BP; Juengsomjit R; Meesakul O; Poomsawat S; Janebodin K; Khovidhunkit SP
Eur J Dent; 2024 Feb; 18(1):297-303. PubMed ID: 37311552
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of USP22 and Ki-67 expression in oral squamous cell carcinoma: An immunohistochemical study.
Apoorva CC; Ananthaneni A; Kumar AJ; Guduru VS; Puneeth HK
J Oral Maxillofac Pathol; 2023; 27(4):679-684. PubMed ID: 38304522
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
He R; Du S; Lei T; Xie X; Wang Y
Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study.
Xu H; Jin X; Yuan Y; Deng P; Jiang L; Zeng X; Li XS; Wang ZY; Chen QM
Sci Rep; 2017 Aug; 7(1):7522. PubMed ID: 28790303
[TBL] [Abstract][Full Text] [Related]
10. The Role of p16
D'Arcangelo D; Tinaburri L; Dellambra E
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28737694
[TBL] [Abstract][Full Text] [Related]
11. Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model.
Kamide D; Yamashita T; Araki K; Tomifuji M; Tanaka Y; Tanaka S; Shiozawa S; Shiotani A
Cancer Sci; 2016 May; 107(5):666-73. PubMed ID: 26918517
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 beta: can it be a target for oral cancer.
Mishra R
Mol Cancer; 2010 Jun; 9():144. PubMed ID: 20537194
[TBL] [Abstract][Full Text] [Related]
13. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study.
Wu MY; Zhuang CX; Yang HX; Liang YR
World J Gastroenterol; 2004 Feb; 10(4):476-80. PubMed ID: 14966901
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma.
de Sousa SO; Mesquita RA; Pinto DS; Gutkind S
J Oral Pathol Med; 2002 Feb; 31(2):78-81. PubMed ID: 11896827
[TBL] [Abstract][Full Text] [Related]
15. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO
J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma.
Krishna A; Bhatt MLB; Singh V; Singh S; Gangwar PK; Singh US; Kumar V; Mehrotra D
Asian Pac J Cancer Prev; 2018 Mar; 19(3):867-874. PubMed ID: 29582647
[TBL] [Abstract][Full Text] [Related]
17. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
